Can You Get GLP-1 in Canada? Exploring Access to Semaglutide and Tirzepatide

Last reviewed: June 11, 2026

Last updated: June 11, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Yes — GLP-1 medications are authorized and marketed in Canada. Health Canada's Drug Product Database lists active drug identification numbers for Ozempic, Wegovy, Rybelsus, Mounjaro and Zepbound, so semaglutide and tirzepatide are both legally available north of the border. What that does not mean is that Canada is a shortcut for someone living in the United States. A Canadian prescription requires a Canadian prescriber, indications are set by Health Canada rather than the FDA, and bringing an unapproved product across the border is a separate legal question with its own answer.

What Is Authorized in Canada

Health Canada operates its own review process and issues a drug identification number, or DIN, for each authorized product and presentation. The Drug Product Database shows multiple active DINs for each of the semaglutide and tirzepatide brands, covering the various strengths and pen configurations sold in that market.

Authorization is product-specific, exactly as it is in the United States. A DIN attaches to a particular brand, strength and dosage form, and it reflects a review of that specific application rather than a general blessing of the molecule.

One practical consequence: the presentations available in Canada do not always match the U.S. lineup, and new strengths often reach the two markets at different times. Assuming that what you read about a U.S. product applies unchanged in Canada is a reliable way to get something wrong.

A Canadian Prescription Requires a Canadian Prescriber

These are prescription-only medications in Canada as they are in the United States. Prescribing authority is regulated provincially through the colleges of physicians and surgeons, so the prescriber has to be licensed in the province where the patient is located.

A U.S. prescription is not valid at a Canadian pharmacy, and a Canadian prescription is not valid at a U.S. pharmacy. That is a licensure boundary rather than a paperwork inconvenience, and no legitimate service works around it.

Canadians also access these medications through a mix of public and private drug plans, and coverage for weight management is contested there too. Provincial formularies and private insurers apply their own criteria, so "available in Canada" and "paid for in Canada" are, as in the United States, two different statements.

Indications Are Set Country by Country

Each regulator approves its own indications based on the application submitted to it, which is why labeling can differ between countries for the same brand. In the United States, the Ozempic label covers three type 2 diabetes indications with no weight-management indication, while the Wegovy label carries the weight-management, cardiovascular and liver indications.

The safe habit is to read the product monograph for the country you are actually in. Canadian product monographs are published through Health Canada, and they — not U.S. prescribing information, and not this article — govern what a Canadian prescriber is working from.

Warning sections diverge too, not just indications. Regulators update labeling on their own timelines as postmarketing data accumulate, so a safety subsection that has been revised or removed in one country's label may still stand in another's. That is one more reason to work from the monograph that applies where you are being treated.

Importing Into the United States Is a Different Question

This is where most people are actually headed when they ask about Canada. The FDA states on its personal importation page that "in most circumstances, it is illegal for individuals to import drugs or devices into the U.S. for personal use because these products purchased from other countries often have not been approved by the FDA for use and sale in the U.S."

The agency describes a narrow enforcement-discretion pathway with conditions that rarely fit this situation: the product must be for a serious condition for which effective treatment may not be available domestically, there must be no commercialization or promotion of the product to U.S. residents, the consumer must affirm in writing that it is for personal use, and the quantity is generally not more than a three-month supply.

Semaglutide and tirzepatide fail the first condition on its face. Approved products for these uses are available domestically, which is precisely why the "no effective treatment available in the U.S." criterion does not apply. The FDA's own summary is blunt: it recommends obtaining medicines only from legal sources within the United States.

Why "Canadian Pharmacy" Websites Deserve Scrutiny

A large share of websites presenting themselves as Canadian pharmacies are neither Canadian nor pharmacies. The maple leaf on the header is a marketing asset, and the fulfillment address is frequently somewhere else entirely.

The verifiable signals are dull but decisive: a named dispensing pharmacy, a provincial licence number you can check with that province's college of pharmacists, and a real prescriber. If a site will ship without a prescription, it has already told you what it is.

Payment method is another tell. Requests for cryptocurrency, wire transfer or gift cards indicate an operation that expects chargebacks and disputes. So does the absence of a physical address, a named pharmacist in charge, or any way to reach a human being about a problem with an order.

Compounded GLP-1s Do Not Travel

Compounded preparations are made by a licensed pharmacy pursuant to a prescription for an individual patient, and they are not approved drug products in any jurisdiction. They are not exportable consumer goods, and a compounded preparation crossing a border is not covered by any of the personal-importation reasoning above.

The FDA has separately announced its intent to restrict GLP-1 active pharmaceutical ingredients intended for use in non-FDA-approved compounded drugs, and to act against marketing that presents compounded products as equivalent to approved ones. Cross-border sourcing of raw peptide material sits squarely in that enforcement picture.

If You Are in the United States

The domestic routes are the approved brands through a licensed prescriber and pharmacy, or compounded preparations through a licensed 503A pharmacy pursuant to an individual prescription. Both involve a real clinician; neither involves a border.

If cost is what pushed you toward looking at Canada, that is a solvable problem worth raising directly with a prescriber, alongside coverage appeals and manufacturer support programs. Importing is the option with the worst risk profile and the least recourse if something arrives wrong.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Are semaglutide and tirzepatide available in Canada?

Yes. Health Canada's Drug Product Database lists active drug identification numbers for Ozempic, Wegovy, Rybelsus, Mounjaro and Zepbound, so both molecules are authorized and marketed in Canada. Authorization is product-specific, attaching to a particular brand, strength and dosage form. The available presentations and the timing of new strengths do not always match the United States lineup, so check the Canadian product monograph rather than assuming U.S. information applies.

Can I use a U.S. prescription at a Canadian pharmacy?

No. Prescribing authority in Canada is regulated provincially, and a prescriber must be licensed in the province where the patient is located. A prescription written by a U.S. clinician is not valid at a Canadian pharmacy, and the reverse is also true. This is a licensure boundary rather than a paperwork formality, and legitimate pharmacies on either side of the border will not work around it.

Is it legal to import GLP-1 medication from Canada into the U.S.?

Generally no. The FDA states that in most circumstances it is illegal for individuals to import drugs into the United States for personal use, because products purchased abroad often have not been FDA approved. The narrow enforcement-discretion pathway requires, among other conditions, that effective treatment is not available domestically. Approved semaglutide and tirzepatide products are available in the United States, so that condition is not met.

How can I tell whether a Canadian pharmacy website is legitimate?

Look for a named dispensing pharmacy, a provincial licence number you can verify with that province's college of pharmacists, and a real prescriber involved in the transaction. Many sites branded as Canadian pharmacies are neither Canadian nor licensed pharmacies, and fulfillment often occurs elsewhere. Any site willing to ship a prescription-only medication without a prescription has already disqualified itself, regardless of its branding.

Do Canadian and U.S. labels approve the same uses?

Not necessarily. Each regulator approves indications based on the application submitted to it, so labeling for the same brand can differ between countries. In the United States, for example, Ozempic carries three type 2 diabetes indications and no weight-management indication, while Wegovy holds the weight-management approval. Read the product monograph published for the country where you are actually being treated, and discuss it with your prescriber.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.